BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7609119)

  • 1. Glucocorticoid remediable aldosteronism: a rare hereditary form of adrenocorticotropic hormone regulated mineralocorticoid hypertension.
    Comiter CV; Capelouto CC; Tobin MS; Dluhy RG; Richie JP
    J Urol; 1995 Aug; 154(2 Pt 1):510-2. PubMed ID: 7609119
    [No Abstract]   [Full Text] [Related]  

  • 2. [Low-renin hypertension and inherited mineralocorticoid diseases].
    Kastelan D; Giljević Z; Perković Z; Plavsić V; Breskovac L; Aganović I; Korsić M
    Lijec Vjesn; 1999; 121(7-8):245-9. PubMed ID: 10573960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Arterial hypertension and mineralocorticoids].
    Molinatti GM; Strumia E
    Folia Endocrinol; 1973 Feb; 26(1):21-48. PubMed ID: 4349746
    [No Abstract]   [Full Text] [Related]  

  • 4. [Genetics in hypertension research. What can we learn from it regarding common essential hypertension?].
    Toka HR; Toka O; Luft FC
    Fortschr Med; 1997 Oct; 115(28):36-8. PubMed ID: 9445830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular basis of glucocorticoid-remediable aldosteronism, a Mendelian cause of human hypertension.
    Lifton RP; Dluhy RG; Powers M; Ulick S; Lalouel JM
    Trans Assoc Am Physicians; 1992; 105():64-71. PubMed ID: 1309006
    [No Abstract]   [Full Text] [Related]  

  • 6. Glucocorticoid-remediable aldosteronism.
    Dluhy RG; Lifton RP
    Endocrinol Metab Clin North Am; 1994 Jun; 23(2):285-97. PubMed ID: 8070423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monogenic mineralocorticoid hypertension.
    Stowasser M; Gordon RD
    Best Pract Res Clin Endocrinol Metab; 2006 Sep; 20(3):401-20. PubMed ID: 16980202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mineralocorticoid receptors, salt, and hypertension.
    Funder JW; Krozowski Z; Myles K; Sato A; Sheppard KE; Young M
    Recent Prog Horm Res; 1997; 52():247-60; discussion 261-2. PubMed ID: 9238855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoid-remediable aldosteronism.
    Dluhy RG; Williams GH
    Cardiovasc Res; 1996 Jun; 31(6):870-2. PubMed ID: 8759241
    [No Abstract]   [Full Text] [Related]  

  • 10. Glucocorticoid-remediable aldosteronism.
    Litchfield WR; Dluhy RG; Lifton RP; Rich GM
    Compr Ther; 1995 Oct; 21(10):553-8. PubMed ID: 8565422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Monogenic hypertension].
    Bähr V; Oelkers W; Diederich S
    Med Klin (Munich); 2003 Apr; 98(4):208-17. PubMed ID: 12715144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two uncommon causes of mineralocorticoid excess. Syndrome of apparent mineralocorticoid excess and glucocorticoid-remediable aldosteronism.
    Ulick S
    Endocrinol Metab Clin North Am; 1991 Jun; 20(2):269-76. PubMed ID: 1879399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inherited forms of mineralocorticoid hypertension.
    Hassan-Smith Z; Stewart PM
    Curr Opin Endocrinol Diabetes Obes; 2011 Jun; 18(3):177-85. PubMed ID: 21494136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mineralocorticoid hypertension. A new form of secondary hypertension?].
    Román O
    Rev Med Chil; 1999 May; 127(5):511-3. PubMed ID: 10451619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension and hypokalemia: unusual syndromes.
    Cruz DN; Perazella MA
    Conn Med; 1997 Feb; 61(2):67-75. PubMed ID: 9066195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mineralocorticoid function of the adrenal cortex under normal conditions and in pathology (review of the literature)].
    Lebedev VP; Vodolazhskaia-Levina EE; Chemidze NP; Khovanskaia MP; Kalashnikova OA
    Vopr Okhr Materin Det; 1971 Feb; 16(2):24-8. PubMed ID: 4933510
    [No Abstract]   [Full Text] [Related]  

  • 17. [Glucocorticoid-remediable aldosteronism (GRA)].
    Ando K
    Nihon Rinsho; 2000 Feb; 58 Suppl 2():668-71. PubMed ID: 11028424
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hypertension and mineralocorticoids. Usefulness of renin and aldosterone measurements].
    Fardella CE; Montero J; Mosso L
    Rev Med Chil; 1999 May; 127(5):604-10. PubMed ID: 10451632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations contributing to human blood pressure variation.
    Karet FE; Lifton RP
    Recent Prog Horm Res; 1997; 52():263-76; discussion 276-7. PubMed ID: 9238856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An approach to mineralocorticoid hormone hypertension.
    Biglieri EG
    Cardiovasc Clin; 1978; 9(1):91-7. PubMed ID: 667888
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.